FDA Eases Access To Life-Saving Gene Therapies For Blood Cancers

benzinga.com/news/fda/25/06/46166652/fda-eases-access-to-life-saving-gene-therapies-for-blood-cancers

The U.S. Food and Drug Administration (FDA) announced on Friday that it has eliminated the Risk Evaluation and Mitigation Strategies (REMS) for currently approved BCMA- and CD19-directed autologous chimeric antigen receptor CAR T cell immunotherapies.
These products are gene therapies…

This story appeared on benzinga.com, 2025-06-30 12:36:39.
The Entire Business World on a Single Page. Free to Use →